Neogen Corp (NEOG): Capital Expenditures

Annual figures by period end, from SEC filings.

$51.30M
Year ended 2026-05-31
-7.9%
3-year compound annual growth
+13.9%
5-year compound annual growth
+13.7%
10-year compound annual growth
$111.40M2010-05-31: $5.43M2011-05-31: $7.80M2012-05-31: $12.41M2013-05-31: $8.90M2014-05-31: $11.54M2015-05-31: $9.62M2016-05-31: $14.22M2017-05-31: $14.58M2018-05-31: $20.95M2019-05-31: $14.66M2020-05-31: $24.05M2021-05-31: $26.71M2022-05-31: $24.43M2023-05-31: $65.76M2024-05-31: $111.40M2025-05-31: $104.60M2026-05-31: $51.30M$51.30M
2010-05-31 Capital Expenditures (USD) 2026-05-31
Period endedCapital ExpendituresChange YoYSource filing
2026-05-31$51.30M-51.0%2026-07-30, From 2025-06-01
2025-05-31$104.60M-6.1%2026-07-30, From 2024-06-01
2024-05-31$111.40M+69.4%2026-07-30, From 2023-06-01
2023-05-31$65.76M+169.2%2025-07-30, From 2022-06-01
2022-05-31$24.43M-8.5%2024-07-30, From 2021-06-01
2021-05-31$26.71M+11.1%2023-08-15, From 2020-06-01
2020-05-31$24.05M+64.1%2022-07-27, From 2019-06-01
2019-05-31$14.66M-30.0%2021-07-30, From 2018-06-01
2018-05-31$20.95M+43.7%2020-07-30, From 2017-06-01
2017-05-31$14.58M+2.5%2019-07-30, From 2016-06-01
2016-05-31$14.22M+47.9%2018-07-27, From 2015-06-01
2015-05-31$9.62M-16.7%2017-07-28, From 2014-06-01
2014-05-31$11.54M+29.7%2016-07-29, From 2013-06-01
2013-05-31$8.90M-28.3%2015-07-30, From 2012-06-01
2012-05-31$12.41M+59.2%2014-07-30, From 2011-06-01
2011-05-31$7.80M+43.5%2013-07-30, From 2010-06-01
2010-05-31$5.43Mn/a2012-07-30, From 2009-06-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Neogen Corp (NEOG)2026-05-31$51.30M-51.0%
QuidelOrtho Corp (QDEL)2025-12-28$188.20M-3.5%
Idexx Laboratories Inc (IDXX)2025-12-31$124.68M+3.1%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$1.13M-80.5%
Alpha Teknova, Inc. (TKNO)2025-12-31$1.15M+2.0%
Immucell Corp (ICCC)2025-12-31$1.25M+168.5%
Aspira Women's Health Inc. (AWHL)2025-12-31$16.0K-56.8%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$3.19M+517.2%
Volitionrx Ltd (VNRX)2025-12-31$89.6K-67.7%

Compare NEOG, QDEL, IDXX, NTLA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗